Dystrophin Gene Transcripts Skipping the Mdx Mutation
Overview
Authors
Affiliations
The mdx mouse, an animal model used to study Duchenne muscular dystrophy, has a nonsense mutation in exon 23 of the dystrophin gene which should result in a truncated protein that cannot be correctly localized at the sarcolemma of the muscle fibers. Immunohistochemical staining with antidystrophin antibodies has shown that while most of the muscle tissue is dystrophin-negative, a small percentage of muscle fibers is clearly dystrophin-positive and has somehow bypassed the primary nonsense mutation. A sensitive nested polymerase chain reaction-based examination of dystrophin gene transcripts around the mdx mutation has revealed several alternatively processed transcripts. Four mRNA species skipped the mutation in exon 23, were in-frame, and could be translated into a shorter but still functional dystrophin protein. Specific tests for these transcripts demonstrated these were also present in normal mouse muscle tissue.
Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches.
Morais P, Zhang R, Yu Y Biomedicines. 2024; 12(6).
PMID: 38927491 PMC: 11201248. DOI: 10.3390/biomedicines12061284.
Hildyard J, Piercy R Biomedicines. 2023; 11(7).
PMID: 37509720 PMC: 10377302. DOI: 10.3390/biomedicines11072082.
The skeletal muscle phenotype of the DE50-MD dog model of Duchenne muscular dystrophy.
Hildyard J, Riddell D, Harron R, Rawson F, Foster E, Massey C Wellcome Open Res. 2023; 7:238.
PMID: 36865375 PMC: 9971692. DOI: 10.12688/wellcomeopenres.18251.1.
Hildyard J, Rawson F, Wells D, Piercy R PLoS One. 2020; 15(9):e0239467.
PMID: 32970731 PMC: 7514052. DOI: 10.1371/journal.pone.0239467.
Suppression of Nonsense Mutations by New Emerging Technologies.
Morais P, Adachi H, Yu Y Int J Mol Sci. 2020; 21(12).
PMID: 32575694 PMC: 7352488. DOI: 10.3390/ijms21124394.